Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Metabolic Surgery Versus GLP-1 Receptor Agonists

NCT06355219 is registered in ClinicalTrials.gov with Ali Aminian as lead sponsor.

NCT NCT06355219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06355219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Metabolic Surgery Versus GLP-1 Receptor Agonists
Lead sponsor
Ali Aminian
Phase
Observational
Overall status
Completed
Start date
January 1, 2010
Completion date
May 20, 2024
Enrollment
3,932 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

all cause mortality, heart failure, macrovascular disease, major adverse cardiovascular events, microvascular disease, nephropathy, obesity, retinopathy, type 2 diabetes mellitus